Balance Sheet

Assets

-7%

-11%

10Y

Currency: USD

	Dec-2000	Dec-2001	Dec-2002	Dec-2003	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	11	15	10	16	56	6	38	69	32	92	104	142	185	215	340	180	182	213	151	341	248	26	92	111
Cash Equivalents	11	15	10	16	56	6	38	69	32	92	104	142	185	215	340	180	182	213	151	341	248	26	92	111
Short-Term Investments	8	20	0	0	0	23	106	51	59	257	242	157	229	200	0	0	0	0	0	0	0	0	0	0
Total Receivables	2	4	7	10	31	62	52	43	186	82	154	92	113	147	325	257	302	529	636	674	728	797	646	809
Accounts Receivables	2	4	7	10	31	62	52	43	186	82	154	92	113	147	325	257	241	482	604	639	663	742	614	776
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61	47	32	35	65	55	32	33
Inventory	3	4	11	29	33	34	28	32	49	45	54	90	70	81	126	175	159	457	381	491	489	531	581	612
Other Current Assets	0	2	1	1	9	55	48	41	49	46	46	65	64	34	32	18	53	87	42	45	55	58	59	56
Total Current Assets	24	44	28	55	129	181	271	236	374	521	600	546	660	676	822	631	696	1 287	1 210	1 552	1 520	1 412	1 378	1 588
PP&E Net	10	24	37	38	55	69	81	96	102	106	118	181	188	188	214	233	125	544	620	605	639	589	550	524
PP&E Gross	10	24	37	38	55	69	81	96	102	106	118	181	188	188	214	233	125	544	620	605	639	589	550	524
Accumulated Depreciation	3	4	6	9	18	25	32	40	50	63	75	87	100	116	133	156	116	209	276	332	395	446	508	564
Intangible Assets	2	6	1	0	0	0	0	0	0	0	2	48	30	27	602	621	263	1 655	1 383	1 305	1 167	1 096	890	732
Goodwill	35	35	28	28	28	28	28	28	28	28	28	28	28	28	210	207	207	426	420	523	593	599	599	597
Other Long-Term Assets	1	1	11	11	49	66	137	155	158	39	46	62	92	161	74	131	61	441	33	22	21	103	56	60
Other Assets	35	35	28	28	28	28	28	28	28	28	28	28	28	28	210	207	207	426	420	523	593	599	599	597
Total Assets	67 N/A	98 +45%	104 +7%	133 +27%	260 +96%	344 +32%	517 +50%	514 0%	661 +28%	693 +5%	794 +15%	864 +9%	997 +15%	1 079 +8%	1 923 +78%	1 823 -5%	1 351 -26%	4 353 +222%	3 666 -16%	4 006 +9%	3 940 -2%	3 799 -4%	3 473 -9%	3 501 +1%
Liabilities
Accounts Payable	2	4	8	23	13	15	17	13	23	19	23	41	27	32	56	59	81	115	102	151	189	166	144	259
Accrued Liabilities	2	4	11	11	48	30	36	41	116	87	110	96	102	126	270	245	248	400	410	464	404	383	403	490
Short-Term Debt	2	0	4	8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	60	179	100
Current Portion of Long-Term Debt	0	0	1	1	0	2	69	14	0	0	0	0	0	0	0	18	18	22	24	48	34	33	37	227
Other Current Liabilities	0	0	0	0	12	52	38	41	65	21	24	8	25	1	1	0	7	18	15	13	50	110	84	54
Total Current Liabilities	6	8	23	42	73	99	160	110	204	126	157	145	154	159	327	321	354	554	550	677	677	753	847	1 130
Long-Term Debt	1	7	9	9	80	90	21	6	0	0	0	0	0	0	425	814	770	2 670	2 675	2 834	2 778	2 692	2 486	2 219
Deferred Income Tax	0	0	0	0	1	0	0	0	0	0	0	0	0	0	73	0	3	1	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	392	115	54	24	89	42	65
Other Liabilities	0	23	24	8	98	160	201	239	235	59	34	28	33	33	36	64	37	232	94	138	100	145	79	198
Total Liabilities	8 N/A	38 +365%	56 +48%	59 +6%	251 +325%	348 +38%	382 +10%	355 -7%	439 +24%	185 -58%	191 +3%	173 -9%	187 +8%	191 +2%	860 +350%	1 199 +39%	1 164 -3%	3 848 +231%	3 434 -11%	3 703 +8%	3 579 -3%	3 501 -2%	3 453 -1%	3 611 +5%
Equity
Common Stock	29	8	8	8	1	1	1	1	1	1	1	1	1	1	1	1	1	3	3	3	3	3	3	3
Retained Earnings	45	70	90	105	174	186	60	49	1	251	317	373	474	531	570	98	372	21	378	287	276	406	490	607
Additional Paid In Capital	77	123	131	170	183	184	196	211	223	255	286	315	337	364	504	535	560	530	607	628	658	692	539	560
Treasury Stock	0	0	0	0	0	2	2	2	2	2	2	2	2	2	2	2	2	0	0	0	0	0	0	0
Other Equity	1	1	0	0	0	0	0	1	1	3	2	5	1	6	11	8	1	8	0	41	25	10	32	66
Total Equity	59 N/A	60 +1%	49 -19%	74 +51%	9 -88%	4 N/A	134 N/A	159 +19%	222 +39%	508 +129%	603 +19%	691 +15%	810 +17%	888 +10%	1 062 +20%	624 -41%	187 -70%	505 +170%	232 -54%	303 +31%	360 +19%	298 -17%	20 -93%	109 N/A
Total Liabilities & Equity	67 N/A	98 +45%	104 +7%	133 +27%	260 +96%	344 +32%	517 +50%	514 0%	661 +28%	693 +5%	794 +15%	864 +9%	997 +15%	1 079 +8%	1 923 +78%	1 823 -5%	1 351 -26%	4 353 +222%	3 666 -16%	4 006 +9%	3 940 -2%	3 799 -4%	3 473 -9%	3 501 +1%
Shares Outstanding
Common Shares Outstanding	32	47	48	55	59	59	59	60	62	65	67	68	70	71	73	74	74	299	299	300	302	304	459	310
Preferred Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Income Statement Balance Sheet Cash Flow Statement

Amneal Pharmaceuticals Inc
F:2DT

Balance Sheet

Balance Sheet Decomposition
Amneal Pharmaceuticals Inc

Balance Sheet
Amneal Pharmaceuticals Inc

See Also

Company

Help

Tools

Stocks

Amneal Pharmaceuticals Inc F:2DT

Balance Sheet

Balance Sheet Decomposition Amneal Pharmaceuticals Inc

Balance Sheet Amneal Pharmaceuticals Inc

See Also

Company

Help

Tools

Stocks

Amneal Pharmaceuticals Inc
F:2DT

Balance Sheet Decomposition
Amneal Pharmaceuticals Inc

Balance Sheet
Amneal Pharmaceuticals Inc